Then, we analyzed the data with 88, 283, 498, and 649 samples of patients with NB from the R2 database, and the results showed that patients with higher expressions of SOX4 have better overall survival probability and relapse-free/progression-free/event-free survival probability compared to those with lower expressions of SOX4 (Figure 3A–D). Here, SOX4 is linked to neuroblastoma.